Advanced search×

Alimentary Pharmacology and Therapeutics

Print ISSN
Electronic ISSN
Impact factor
Usage rank
Article count
Free count
Free percentage
PDFs via platforms
Ebscoatoz, CSA, Ovid from 2000, Ebsconet, Wiley from 1987, Ebsco, Gale, and Proquest

  1. Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough.

    Alimentary Pharmacology and Therapeutics 40(8):966 (2014) PMID 25109844

    Gastro-oesophageal reflux disease (GERD) may contribute to the onset of chronic cough (CC); however, the multichannel intraluminal impedance-pH (MII-pH) monitoring is often within the normal range and the response to proton pump inhibitors (PPIs) unsatisfactory. The measure of impedance baseline (IB...
  2. Letter: herbal hepatotoxicity - an update on traditional Chinese medicine preparations; authors' reply.

    Alimentary Pharmacology and Therapeutics 40(6):738 (2014) PMID 25123394

  3. Randomised clinical study: comparison of acceptability, patient tolerance, cardiac stress and endoscopic views in transnasal and transoral e...

    Alimentary Pharmacology and Therapeutics 40(5):467 (2014) PMID 25039412

    We prospectively recruited 157 patients (83 females/74 males) mean age 57 years. The Fujinon EG530N (5.9 mm) and EG530WR (9.4 mm) endoscopes were used. The endoscopist and all patients completed detailed questionnaires regarding tolerability, acceptance and quality of endoscopy using standard visual...
  4. Systematic review: the association between eosinophilic oesophagitis and coeliac disease.

    Alimentary Pharmacology and Therapeutics 40(5):422 (2014) PMID 25041372

    The relationship between eosinophilic oesophagitis (EoE) and coeliac disease (CD) remains controversial, with studies yielding varied results. To systematically review the evidence of a possible association between both diseases. Electronic searches were performed with keywords relating to EoE and C...
  5. The pharmacokinetics, pharmacodynamics and safety of oral doses of ilaprazole 10, 20 and 40 mg and esomeprazole 40 mg in healthy subjects: a...

    Alimentary Pharmacology and Therapeutics 40(5):548 (2014) PMID 25041486

    Ilaprazole, a proton pump inhibitor (PPI) currently in clinical use, may provide improved acid suppression vs. other PPIs. To compare the pharmacodynamic and pharmacokinetic profiles of ilaprazole and esomeprazole. A phase 1, randomised, open-label, single-centre, 4-period crossover study was conduc...
  6. Letter: effects of oxycodone and tapentadol dosage on gastrointestinal function - author's reply.

    Alimentary Pharmacology and Therapeutics 36(7):689 (2012) PMID 22966804

  7. Letter: anti-TNFs and psoriasis - friends or foes? Authors' reply.

    Alimentary Pharmacology and Therapeutics 36(5):498 (2012) PMID 22860614

  8. The Fatigue Questionnaire has a good test-retest profile in IBD.

    Alimentary Pharmacology and Therapeutics 35(5):621 (2012) PMID 22300126

  9. Anti-TNF associated psoriasis.

    Alimentary Pharmacology and Therapeutics 35(2):308 (2012) PMID 22172080

  10. Microscopic colitis and disease associations: authors' reply.

    Alimentary Pharmacology and Therapeutics 34(7):820 (2011) PMID 21896043